Newly diagnosed multiple myeloma patients with CD56 expression benefit more from autologous stem cell transplantation

BACKGROUND: Several studies showed that lack of CD56 expression was a poor prognostic factor for patients with newly diagnosed multiple myeloma (NDMM). However, other studies were not able to confirm the prognostic value of CD56 in NDMM. This study aimed to evaluate the prognostic value of CD56 expr...

Descripción completa

Detalles Bibliográficos
Autores principales: Geng, Chuanying, Zhou, Huixing, Wang, Huijuan, Li, Yanchen, Leng, Yun, Zhang, Zhiyao, Jian, Yuan, Yang, Guangzhong, Chen, Wenming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9783713/
https://www.ncbi.nlm.nih.gov/pubmed/36564753
http://dx.doi.org/10.1186/s12885-022-10382-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9783713/
https://www.ncbi.nlm.nih.gov/pubmed/36564753
http://dx.doi.org/10.1186/s12885-022-10382-0

Ejemplares similares